首页> 美国卫生研究院文献>PLoS Clinical Trials >Molecular mechanisms involved in drug-induced liver injury caused by urate-lowering Chinese herbs: A network pharmacology study and biology experiments
【2h】

Molecular mechanisms involved in drug-induced liver injury caused by urate-lowering Chinese herbs: A network pharmacology study and biology experiments

机译:降尿酸盐引起的药物性肝损伤的分子机制:网络药理研究和生物学实验

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

As an important part of the comprehensive treatment methods, the urate-lowering Chinese herbs could provide favorable clinical effects on hyperuricemia in its ability to invigorate spleen and remove dampness. Owing to the long-term duration, it brought up the potential adverse reactions (ADRs) and concerns about the drug-induced liver injury from these herbs. To address this problem, the bioinformatics approaches which combined the network pharmacology, computer simulation and molecular biology experiments were undertaken to elucidate the underlying drug-induced liver injury molecular mechanisms of urate-lowering Chinese herbs. Several electronic databases were searched to identify the potential liver injury compounds in published research. Then, the putative target profile of liver injury was predicted, and the interaction network was constructed based on the links between the compounds, corresponding targets and core pathways. Accordingly, the molecular docking simulation was performed to recognize the representative compounds with hepatotoxicity. Finally, the cell experiments were conducted to investigate the biochemical indicators and expression of the crucial protein that were closely associated with liver injury. In conclusion, the current research revealed that the compounds with potential liver injury including diosgenin, baicalin, saikosaponin D, tetrandrine, rutaecarpine and evodiamine from urate-lowering Chinese herbs, could lead to decline the survival rate of L-02 cell, increase the activities of aspartate aminotransferase (AST), alanine aminotransferase (ALT), lactate dehydrogenase (LDH) and alkaline phosphatase (ALP) in cell-culture medium, enhance the expression of p-p38/p38, while the p38 inhibitor could achieve the trend of regulating and controlling liver injury. These research findings bring further support to the growing evidence that the mechanism of the liver injury induced by the compounds from urate-lowering Chinese herbs may be associated with the activation of p38α.
机译:降尿酸盐中草药作为综合治疗方法的重要组成部分,具有健脾除湿的作用,对高尿酸血症具有良好的临床疗效。由于长期使用,它引起了潜在的不良反应(ADR),并引起了这些草药引起的药物性肝损伤的担忧。为了解决这个问题,采取了将网络药理学,计算机模拟和分子生物学实验相结合的生物信息学方法,来阐明降尿酸中药潜在的药物性肝损伤的分子机制。搜索了几个电子数据库,以确定已发表的研究中潜在的肝损伤化合物。然后,预测了肝损伤的假定靶标谱,并基于化合物,相应靶标和核心途径之间的联系构建了相互作用网络。因此,进行分子对接模拟以识别具有肝毒性的代表性化合物。最后,进行细胞实验以研究与肝损伤密切相关的生化指标和关键蛋白的表达。总之,目前的研究表明,降低尿酸的中草药中的薯os皂苷元,黄ical苷,皂苷D,粉防己碱,芸苔芸香碱和依夫二胺等具有潜在肝损伤作用的化合物可能会降低L-02细胞的存活率,增加其活性。天冬氨酸转氨酶(AST),丙氨酸转氨酶(ALT),乳酸脱氢酶(LDH)和碱性磷酸酶(ALP)在细胞培养基中的表达增强p-p38 / p38的表达,而p38抑制剂可达到调节的趋势和控制肝损伤。这些研究结果为越来越多的证据提供了支持,这些证据表明降尿酸盐的中草药化合物诱导的肝损伤机制可能与p38α的激活有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号